Malignant Mastocytosis — Trials

Malignant Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 67%
Top sponsor: Cogent Biosciences, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04996875	(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis	recruiting	Phase 2	140	Cogent Biosciences, Inc.INDUSTRY	14	Sep 15, 2026	clinicaltrials
NCT05362773	A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies	active not recruiting	Phase 1	130	MacroGenicsINDUSTRY	1	Jul 28, 2026	clinicaltrials
NCT06327685